Current Management Options for Hereditary Angioedema
@article{Bork2012CurrentMO, title={Current Management Options for Hereditary Angioedema}, author={K. Bork}, journal={Current Allergy and Asthma Reports}, year={2012}, volume={12}, pages={273-280} }
The aim of treatment of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (HAE-C1-INH) is either treating acute attacks or preventing attacks by using prophylactic treatment. For treating acute attacks, plasma-derived C1 inhibitor (C1-INH) concentrates, a bradykinin B2 receptor antagonist, and a recombinant human C1-INH are available in Europe. In the United States, a plasma-derived C1-INH concentrate, a bradykinin B2 receptor antagonist, and a plasma kallikrein inhibitor have… CONTINUE READING
21 Citations
Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema
- Medicine
- Expert review of clinical immunology
- 2018
- 3
- PDF
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
- Medicine
- 2013
- 7
Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
- Medicine
- Immunotherapy
- 2014
- 28
Acute Management of Hereditary Angioedema Attacks.
- Medicine
- Immunology and allergy clinics of North America
- 2017
- 5
Current pharmacotherapy of bradykinin-mediated angioedema
- Medicine
- Expert opinion on pharmacotherapy
- 2013
- 35
Angiotensin-converting enzyme inhibitor-induced angioedema--a dangerous new epidemic.
- Medicine
- Acta dermato-venereologica
- 2014
- 45
- PDF
Acquired complement C1 esterase inhibitor deficiency in a patient with a rare SERPING1 variant with unknown significance
- Medicine
- BMJ Case Reports
- 2019
- 1
Hereditary angioedema: what the gastroenterologist needs to know
- Medicine
- Clinical and experimental gastroenterology
- 2014
- 18
- PDF
Critical upper airway obstruction in sporadic angioedema responding to C1-esterase inhibitor
- Medicine
- BMJ Case Reports
- 2013
- 2
References
SHOWING 1-10 OF 45 REFERENCES
Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
- Medicine
- The Journal of allergy and clinical immunology
- 2007
- 115
Long-Term Prophylaxis of Hereditary Angioedema with a Pasteurized C1 Inhibitor Concentrate
- Medicine
- International Archives of Allergy and Immunology
- 2010
- 18
Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate.
- Medicine
- The New England journal of medicine
- 1996
- 288
Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
- Medicine
- The Journal of allergy and clinical immunology
- 2010
- 188
Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency.
- Medicine
- The Journal of allergy and clinical immunology
- 1989
- 146
Hereditary Angioedema: Long-Term Treatment with One or More Injections of C1 Inhibitor Concentrate per Week
- Medicine
- International Archives of Allergy and Immunology
- 2010
- 45
Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema.
- Medicine
- Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
- 2008
- 62
Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency.
- Medicine
- The Journal of allergy and clinical immunology
- 2006
- 155
Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
- Medicine
- The Journal of allergy and clinical immunology
- 2009
- 286
Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients.
- Medicine
- Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
- 2008
- 167